Form 4: Charles River Laboratories Executive Sells Shares

Joseph W. LaPlume, EVP of Corporate Strategy & Development at Charles River Laboratories, sold 500 shares of common stock at a price of $145.41 on May 13, 2025.

Summary

• On May 13, 2025, Joseph W. LaPlume, the EVP of Corporate Strategy & Development at Charles River Laboratories International, Inc., sold 500 shares of the company's common stock.
• The sale was executed at a price of $145.41 per share.
• Following the transaction, LaPlume directly owns 19,513 shares of Charles River Laboratories' common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an executive. It doesn't inherently convey positive or negative sentiment, but the market may interpret executive sales in various ways.

Industry Context

Executive stock sales are a common occurrence and are often scrutinized by investors for insights into a company's prospects. It's important to consider the size of the sale relative to the executive's holdings and the overall trading volume of the stock.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders, depending on how the market interprets the transaction.

Key Dates

Keywords

Charles River Laboratories, CRL, LaPlume, Executive Stock Sale, Form 4, Beneficial Ownership, Corporate Strategy, Stock Sale